Cartridge-based PCR system Circulating cell-free DNA NSCLC Sanger sequencing epidermal growth factor receptor mutations liquid biopsy

Journal

Expert review of molecular diagnostics
ISSN: 1744-8352
Titre abrégé: Expert Rev Mol Diagn
Pays: England
ID NLM: 101120777

Informations de publication

Date de publication:
09 Jan 2024
Historique:
medline: 9 1 2024
pubmed: 9 1 2024
entrez: 9 1 2024
Statut: aheadofprint

Résumé

Limited information exists on epidermal growth factor receptor We describe the prevalence of EGFR mutations in NSCLC patients in two high-volume clinical centers in Greece and compare key methods used for their determination. 857 FFPE samples from NSCLC patients were tested for EGFR mutations at University of Crete (UoC; The prevalence of The frequency of

Sections du résumé

BACKGROUND UNASSIGNED
Limited information exists on epidermal growth factor receptor
RESEARCH DESIGN AND METHODS UNASSIGNED
We describe the prevalence of EGFR mutations in NSCLC patients in two high-volume clinical centers in Greece and compare key methods used for their determination. 857 FFPE samples from NSCLC patients were tested for EGFR mutations at University of Crete (UoC;
RESULTS UNASSIGNED
The prevalence of
CONCLUSION UNASSIGNED
The frequency of

Identifiants

pubmed: 38193169
doi: 10.1080/14737159.2024.2303320
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Kleita Michaelidou (K)

Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.

Ioannis Karniadakis (I)

Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.

Varvara Pantelaion (V)

Department of Pathology, Evangelismos General Hospital, Athens, Greece.

Chara Koutoulaki (C)

Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.

Eleni Mpoukla (E)

Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece.

Konstantinos Folinas (K)

Department of Medical Oncology, Evangelismos General Hospital, Athens, Greece.

Pantelis Dimaras (P)

Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece.

Maria A Papadaki (MA)

Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.

Anastasios V Koutsopoulos (AV)

Department of Pathology, University General Hospital of Heraklion, Crete, Greece.

Dimitrios Mavroudis (D)

Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.
Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece.

Christine Vourlakou (C)

Department of Pathology, Evangelismos General Hospital, Athens, Greece.

Konstantinos Mavridis (K)

Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece.

Sofia Agelaki (S)

Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.
Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece.

Classifications MeSH